The association between three single nucleotide polymorphisms (SNPs) in the hMSH3 gene and sporadic colon cancer with microsatellite instability (MSI) was analyzed. Of the three SNPs observed in this population, SNPs at residues 235 and 693 were novel, while that at residue 3133 was previously described. The SNPs at residues 235 and 3133 caused amino acid substitutions, V79I and T1045A, respectively. We analyzed the allele frequencies of the three SNPs in samples from 19 patients with sporadic colon cancer with MSI and 90 healthy controls. We found that the V79 allele frequency was significantly higher in the tumor samples than in controls. In addition, the frequency of the G693 allele showed a higher trend in the tumor samples than in controls. These results indicated that some SNPs in the hMSH3 gene were associated with colon cancer with MSI.
Introduction
Human MSH3 (hMSH3) is one of the DNA mismatch repair proteins that binds hMSH2 to form a heterodimer hMutS , which recognizes mainly 2-4 loop mismatches (Acharya et al. 1996; Palombo et al. 1996; Drummond et al. 1997; Marra et al. 1998; Genschel et al. 1998; Nakajima et al. 1999) . The gene for hMSH3 was cloned (Fujii and Shimada 1989; Watanabe et al. 1996) , and located on chromosome 5q11-13 (Anagnou et al. 1988) . Defective mismatch repair causes microsatellite instability (MSI) that indicates hypermutability (Modrich and Lahue 1996) . Frameshift mutations in the hMSH3 gene are considered to affect the tumorigenesis of colon cancer with MSI (Malkhosyan et al. 1996; Risinger et al. 1996; Ikeda et al. 1998; Orimo et al. 1999) . In addition, the repeat number of a 9-bp repeat polymorphism in exon 1 of the hMSH3 gene (Nakajima et al. 1995) was altered in a sporadic colon cancer with MSI (Orimo et al. 1999) .
The genes for the other mismatch repair proteins, hMSH2 and hMLH1, were often mutated in sporadic colon cancer with MSI (Eshleman and Markowitz 1996) . However, the role of the mismatch repair protein genes in a genetic background of sporadic colon cancer with MSI has not been well investigated. Particularly, there have been no reports on association between the hMSH3 gene and sporadic colon cancer with MSI. We report here an association study between three single nucleotide polymorphisms (SNPs) in the hMSH3 gene and sporadic colon cancer with MSI.
Subjects and methods
Samples. Genomic DNA of 19 Japanese patients with sporadic colon cancer with MSI was extracted from both normal and cancerous tissues, as described previously . As a control, genomic DNA of 90 healthy Japanese volunteers was extracted from peripheral blood, or hair. The samples were extracted after informed consent had been obtained.
Microsatellite instability (MSI).
The following markers were employed to estimate MSI, as described elsewhere ). BAT25, BAT26, and the (A) 10 repeat of transforming growth factor (TGF)-RII were used for the mononucleotide repeat, and DCC, D5S107, D17S261, and the (GT) 3 repeat of TGF-RII were used for the dinucleotide repeat.
Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP). A PCR-SSCP analysis was performed, using [γ-
33 P]ATP-labeled primers that amplified 24 exons based on the genomic sequence of the hMSH3 gene (Watanabe et al. 1996) . The nucleotide sequences of the PCR primers are available upon request. The PCR conditions were described elsewhere (Orimo et al. 1999) . The PCR products were heat-denatured, applied to a 0.5ϫ MDE gel (FMC BioProducts, Rockland, ME, USA), and electrophoresed at 6 W for 12 h at room temperature. The gel was dried and exposed to an X-ray film at Ϫ70°C for 3-5 days.
Direct nucleotide sequencing. Each SSCP band was cut out and eluted with water, and then the eluate was re-amplified with nonlabeled primers. The PCR product was labeled using an ABI PRISM Dye Terminator Cycle Sequencing Kit, and nucleotide sequencing was carried out with an ABI 373 autosequencer (Perkin-Elmer, Norwalk, CT, USA).
Digestion with restriction enzymes. To detect a single base substitution, PCR was carried out with nonlabeled primers and the PCR product was digested with one of the following restriction enzymes; BsaAI for the polymorphism at cDNA residue 235 in exon 1, AciI for residue 693 in exon 4, and HhaI for residue 3133 in exon 23. The digested PCR products were analyzed on 8% polyacrylamide gel electrophoresis. The numbers of cDNA residues were calculated from the first ATG (Fujii and Shimada 1989) .
Statistical analysis. The
2 test was used to analyze significant differences in allele frequencies of the polymorphisms between the samples from the normal subjects and the tumor samples. A level of P Ͻ 0.05 was considered statistically significant.
Results and discussion
By PCR-SSCP-direct nucleotide sequencing, we found single nucleotide polymorphisms in exons 1, 4, and 23 of the hMSH3 gene in colon cancer samples. They were not somatic changes, because cancer samples and noncancerous tissues from the same patients showed identical genotypes. In the reported sequence (Watanabe et al. 1996) , residue 235 in exon 1 is G, and the amino acid residue at codon 79 is valine. We found a base substitution in two samples in which residue 235 was A, and the amino acid residue at codon 79 would change to isoleucine. In exon 4, residue 693 is G and the amino acid residue at codon 231 is proline, but nine samples showed A at 693, which would not change the amino acid residue at codon 231. The base substitutions in exons 1 and 4 were novel. In exon 23, residue 3133 is A and the amino acid residue at codon 1045 is threonine, but nine samples showed G at 3133 and the amino acid residue at codon 1045 would change to alanine. This base substitution was reported in a hMSH3 cDNA (Acharya et al. 1996) , but its allele frequency has not been investigated.
We searched for these three base substitutions in the DNA samples from the 90 healthy Japanese volunteers by digestion with restriction enzymes. The characteristics of the base substitutions are summarized in Table 1 . Because the base substitution in exon 4 did not change the amino acid residue, it was a polymorphism. The other two base substitutions changed the encoded amino acid residues, but these base substitutions were common in the normal population, suggesting that they were also polymorphisms.
An association study was performed between the three SNPs and sporadic colon cancer with MSI. We analyzed 19 MSI tumor samples and the 90 healthy control samples. Table 2 shows the allele frequencies of each SNP in the tumor samples and the samples of the healthy controls. Although the number of tumor samples was not very large, it was possible to calculate significant differences between tumor samples and controls. The Val79 (G235) allele frequency was significantly higher in the tumor samples than in controls (P Ͻ 0.05). The G693 at codon 231 allele frequency was higher in the tumor samples than in controls, although the trend did not show a significant difference (P ϭ 0.052). No difference was found in 1045 (Thr or Ala) allele frequency between the tumor samples and controls.
Because Val79 is the more common allele, hMSH3 function with Val79 may not be defective. In addition, Val79 was not in linkage disequilibrium with the other two SNPs. The frequency of seven haplotypes of the three SNPs showed no significant differences between 28 informative chromosomes in tumor samples and 82 informative chromosomes in controls (data not shown). However, the Val79 allele could be in linkage disequilibrium with other SNPs, which would change the protein function, or with mutations in adjacent genes, which may be associated with the tumorigenesis.
Defective function of the hMSH3 gene may influence the tumorigenesis of colon cancer with MSI (Malkhosyan et al. 1996; Risinger et al. 1996; Ikeda et al. 1998; Orimo et al. 1999 ). Although we did not search for cancers without MSI, which are not considered to be associated with defective mismatch repair, the present study revealed that some SNPs At residue 235, the size of the polymerase chain reaction (PCR) fragment (171 bp) corresponded to three repeats in the 9-bp repeat polymorphism (Nakajima et al. 1995) . Six repeat samples showed a 198-bp fragment, and the digested allele yielded fragments of 176 ϩ 22 bp. Heterozygosity was calculated in 90 healthy controls according to the method of Chakraborty et al. (1988) in the hMSH3 gene were associated with sporadic colon cancer with MSI in a Japanese population.
